---
title: "Informed Consent Template for Research Data Use"
version: 1
last_updated: "2025-10-10"
author: "SDX Contributors"
---

# Informed Consent for Use of Health Data in Research

> ⚠️ **Disclaimer:** This is a template for demonstration purposes only.  
> Use in actual research requires IRB/legal review. All placeholders must be replaced with real values before implementation.

**Project/Study Title:** Example Health Data Study  
**Institution/Organization:** SDX Research Institute  
**Version Date:** 2025-10-10  
**IRB Protocol Number:** IRB-2025-12345

---

## 1. Key Information
You are being asked to allow the use of your health information for research.  
Before you decide, please read this form carefully and ask any questions you may have.  
Your participation is completely voluntary.

---

## 2. Purpose of the Research
The purpose of this research is to improve understanding of health conditions and care delivery by analyzing de-identified patient data.  
Your data may help develop better tools, treatments, and technologies for patients in the future.

---

## 3. Procedures
If you agree:

- Researchers will use data already collected as part of your care.
- No additional tests or visits are required.
- Your data will be coded or de-identified before use in research, following HIPAA Safe Harbor (45 CFR 164.514(b)(2)) or Expert Determination.
- Data may be shared with approved research partners or institutions under strict confidentiality agreements and Data Use Agreements where applicable.
- Only authorized personnel will access your information.

---

## 4. Risks and Discomforts
There are no physical risks to you.  
Although every effort will be made to protect your privacy, there is a small risk that someone could identify you from shared data.  

**Security measures:**

- Data will be encrypted in transit and at rest.
- Access is role-based (least privilege), logged, and audited.
- Regular security assessments are performed.

---

## 5. Benefits
There may be no direct benefit to you.  
However, your data may help researchers advance medical knowledge, improve diagnostic tools, or develop better treatments.

---

## 6. Confidentiality and Data Protection
- Personal identifiers (e.g., name, address) will be removed or replaced with a study code.
- Data will be retained for 5 years or until the completion of the study, then securely destroyed or archived in de-identified form.
- International transfers will follow appropriate safeguards (e.g., Standard Contractual Clauses).
- All use of your information will comply with applicable privacy laws (e.g., HIPAA, GDPR).

---

## 7. Voluntary Participation
Taking part in this research is your choice.  
Refusing will not affect your medical care or relationship with your healthcare providers.

---

## 8. Withdrawal of Consent
You may withdraw your consent at any time by contacting the research team.  
After withdrawal:

- New uses of your data will cease.
- Data already used in analyses, publications, or shared de-identified datasets cannot be retracted, but further sharing will stop where feasible.

---

## 9. Future Use of Data
You may choose whether your de-identified data can be stored for future research, including commercial applications:

- [ ] Yes  [ ] No – I give permission for my data to be used for future approved studies.  
- [ ] Yes  [ ] No – I do not give permission for my data to be used in future studies.  
- [ ] Yes  [ ] No – My data may be used for commercial research, including AI/ML model training.  
- [ ] Acknowledge – I understand I will not receive financial benefits from downstream products.  
- [ ] Yes  [ ] No – I wish/do not wish to be recontacted for future studies.  
- [ ] Yes  [ ] No – Individual research results will/will not be returned.

---

## 10. Contact Information
If you have questions or wish to withdraw consent, please contact:

**Principal Investigator:** Dr. Jane Smith, jane.smith@sdx.org, +1 (555) 123-4567  
**Ethics/IRB Contact:** irb@sdx.org  
**Data Controller:** SDX Research Institute, 123 Research Lane, City, Country  
**Data Protection Officer:** dpo@sdx.org  
**For GDPR complaints:** Data Protection Authority, City, Country

---

## 11. Authorization and Signatures

| Role | Name | Signature | Date |
|------|------|-----------|------|
| Participant / Patient |  |  |  |
| Parent/Guardian (if applicable) |  |  |  |
| Participant Assent (for minors, if applicable) |  |  |  |
| Researcher |  |  |  |
| Witness (optional) |  |  |  |

**HIPAA Authorization Elements (US-specific)**:

- Description of PHI to be used/disclosed and by whom/recipients
- Purpose of disclosure
- Expiration date/event
- Statement on right to revoke and instructions
- Notice of potential re-disclosure
- Statement on treatment/payment eligibility
- Copy of this form will be provided to participant

---

## 12. Jurisdiction-Specific Notices (e.g., GDPR)
- Purposes and legal basis of processing
- Categories of personal data
- Recipients and transfers
- Retention period
- International transfer safeguards
- Data subject rights: access, rectification, erasure, restriction, portability, objection
- Right to lodge a complaint with supervisory authority

---

### References
- [NIH Office of Science Policy – Informed Consent Resource (PDF)](https://osp.od.nih.gov/wp-content/uploads/Informed-Consent-Resource-for-Secondary-Research-with-Data-and-Biospecimens.pdf)  
- [NIA Informed Consent Template (Word)](https://www.nia.nih.gov/sites/default/files/2022-03/nia-informed-consent-template.docx)  
- [NIH ClinicalTrials.gov Example (PDF)](https://cdn.clinicaltrials.gov/large-docs/34/NCT05148234/ICF_001.pdf)
